Canagliflozin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 100 mg and 300 mg
Reference Brands: Invokana(US & EU)
Category:
Diabetes
Canagliflozin, an SGLT2 inhibitor, blocks renal glucose reabsorption, increasing urinary glucose excretion. This lowers blood glucose in type 2 diabetes. Benefits include improved glycemic control, weight loss, reduced blood pressure, and decreased cardiovascular and renal risks, with a low hypoglycemia risk.
Canagliflozin tablets is available in Tablets
and strengths such as 100 mg and 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Canagliflozin tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Canagliflozin tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Canagliflozin is an oral sodium-glucose co-transporter 2 (SGLT2) inhibitor used for managing type 2 diabetes and reducing cardiovascular and renal risks. Approved by the FDA in 2013 under the brand Invokana (100 mg, 300 mg), it received EU approval via centralized procedure the same year. It may be used as monotherapy or in combination with other antidiabetic agents. Canagliflozin lowers blood glucose by promoting urinary glucose excretion. Periodic renal assessment is recommended. Through Pharmatradz.com, B2B pharmaceutical buyers can source Canagliflozin from globally audited manufacturers and exporters, ensuring compliance with USA FDA and EU EMA regulatory standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing